Hosted by Positive Aging Sourcebook
Advances Offer Hope and Better Quality of Life
In a recent live discussion Dr. Drew Falconer, Director of the Inova Parkinson’s and Movement Disorders Center, shared encouraging updates on Parkinson’s disease and other movement disorders.
Joined by Steve Gurney, Dr. Falconer emphasized that while these conditions are serious, modern medicine provides numerous effective tools for management, allowing many people to live active, fulfilling lives. What follows is a summary of their discussion.
Parkinson’s Is Treatable: A Chemical Deficiency, Not a Life Sentence
Dr. Falconer explained that Parkinson’s disease fundamentally stems from a deficiency of dopamine, a key neurotransmitter in the brain. The brain itself functions well, but low dopamine levels lead to motor symptoms. This distinction is crucial: the stereotypical image of advanced, debilitating Parkinson’s often reflects untreated disease.
As of 2026, more than 30 treatments have been approved to address this dopamine deficiency, with 15 new options emerging in the last decade alone. Life expectancy for people with Parkinson’s matches that of the general population when properly managed. “We can keep pushing, we can get people doing things that they never thought they could do,” Dr. Falconer noted.
Tremors: When to Pay Attention
Shakiness is a normal physiologic response—triggered by caffeine, stress, low blood sugar, fatigue, or even aging-related muscle loss. Persistent tremor, especially during actions like holding a cup or writing, warrants medical evaluation.
Essential tremor, affecting about 10 million Americans, is the most common pathologic tremor. It often runs in families and improves with treatments like propranolol (especially the extended-release form) or primidone. Alcohol can temporarily suppress it due to its effect on the cerebellum, which can aid diagnosis.
Accurate Diagnosis Matters
Parkinson’s has objective tests:
- DATscan (a type of PET scan imaging the dopamine system, available since 2010) with >90% accuracy.
- Syn-One skin biopsy (detects phosphorylated alpha-synuclein) with ~93% accuracy.
Conditions that can mimic Parkinson’s include normal pressure hydrocephalus, cervical spine arthritis, and certain dementias. Differentiating them is essential, as treatments differ.
Exercise and Community: Powerful Medicine
One of the strongest messages was the transformative power of movement. “The best treatment for you is to move,” Dr. Falconer stated. Exercise benefits motor symptoms, mood, sleep, constipation, and overall well-being. Patients often report dramatic improvements through activities like boxing, dancing, rock climbing, or gym workouts—many discovering these after diagnosis.
Community programs, such as those offered at Inova Parkinson’s and Movement Disorders Center (IPMDC) (120 free programs per month), foster connections and motivation. Participants frequently form deep friendships and regain a sense of purpose.
Addressing Common Questions
Heredity and Prevention: Most Parkinson’s (especially onset after 60) is not strongly hereditary. Lifetime risk rises only slightly (from ~5% to 6%) with a first-degree relative. No supplements prevent it; regular exercise offers the best protection.
Dementia Risk: Cognitive issues occur in about 14% of Parkinson’s cases—far from inevitable—and differ from Alzheimer’s dementia. Normal age-related changes are common to everyone.
Depression and Anxiety: These are common but treatable, often independent of Parkinson’s itself. Stabilizing dopamine, therapy, and staying engaged help significantly.
Advanced Options:
- Newer formulations like Crexont (extended-release carbidopa-levodopa) provide smoother, longer-lasting relief with fewer daily doses.
- Subcutaneous infusion devices (e.g., Vyalev) bypass gut absorption issues for more stable delivery.
- Deep Brain Stimulation (DBS) remains highly effective for appropriate candidates, with long-term data showing major improvements in quality of life and “off” time. Focused ultrasound is another option for tremors.
Other Conditions: MSA (Multiple System Atrophy) is rarer and harder to treat. Tardive dyskinesia (from certain medications blocking dopamine) has effective new treatments like Ingrezza. Camptocormia (bent spine) benefits most from physical therapy.
Seek Specialist Care
Dr. Falconer stressed the value of movement disorder specialists, who manage far more Parkinson’s cases than general neurologists. Only about 7% of patients currently see one, per Medicare data. Patients should feel empowered to find a provider who aligns with their goals—medicine is a collaborative relationship.
A Message of Hope
The discussion highlighted rapid progress in the field. People should not rely on outdated information from decades ago. With proper diagnosis, modern treatments, exercise, and community support, Parkinson’s and related conditions need not define or limit one’s life.
For those experiencing symptoms or supporting loved ones, consulting a movement disorders specialist can open doors to effective management and renewed vitality. The future continues to brighten with ongoing research and innovation.
